Vultr’s Post

🧬 A fascinating session at RAISE Summit with Dirk Van Hyfte, MD, Ph.D., CTO & Co-founder of IPA (ImmunoPrecise Antibodies) at #Vultr Booth #46. Dirk introduced #HYFT technology, an #AINativeBiological framework that’s redefining drug discovery. By unifying sequence, structure, and function, HYFT enables zero-shot discovery of orphan proteins, rare mutations, and disordered regions — far beyond traditional homology-based approaches. 💡 IPA runs HYFT on #VultrCloudGPU to accelerate retrieval, fine-tuning, and multi-omics integration for scalable, AI-driven research. #RAISESummit #Vultr #BioStrand #AI #DrugDiscovery #LifeSciences #GenAI #CloudInfrastructure #AIinHealthcare